People · Operator
Named in public records as an officer, director or promoter · active 2014–2014 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| KEW Group Inc. | — | Biotechnology | Series B | $32.9M | $666.7M | 2014 |
Scott Kathleen Howell at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Scott Kathleen Howell on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Norman C. Selby | 1 | 4 |
| John C. Sullivan | 1 | 2 |
| Joyce C. Erony | 1 | 2 |
| Raju J. Kucherlapati | 1 | 1 |
| Raju Kathleen Kucherlapati | 1 | 1 |
| Valerie Kathleen Friedman | 1 | 1 |
| Mary Kathleen Behrens Wilsey | 1 | 1 |
| Jeffrey J. Elton | 1 | 1 |
| Valerie J. Friedman | 1 | 1 |
| Scott R. Schell | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.